drugset / Trial / NCT03085056
Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety and tolerability of this treatment combination of paclitaxel and trametinib. Additionally, this study aims to to find out what effects the combination of paclitaxel and trametinib has on the shrinkage and growth of anaplastic thyroid cancer.
Timeline
- Start
- 2017-03-15
- Primary completion
- 2026-09
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 80 mg/m2 | — |
| Subject | Trametinib | Small molecule | 2 mg | Oral |